Tomi Environmental Solutions Inc   (TOMZ)
Other Ticker:  
Price: $1.0400 $0.01 1.108%
Day's High: $1.05 Week Perf: -4.59 %
Day's Low: $ 1.03 30 Day Perf: 9.46 %
Volume (M): 6 52 Wk High: $ 1.39
Volume (M$): $ 6 52 Wk Avg: $0.79
Open: $1.03 52 Wk Low: $0.45

 Market Capitalization (Millions $) 21
 Shares Outstanding (Millions) 20
 Employees -
 Revenues (TTM) (Millions $) 9
 Net Income (TTM) (Millions $) -3
 Cash Flow (TTM) (Millions $) -3
 Capital Exp. (TTM) (Millions $) 0

Tomi Environmental Solutions Inc

   Company Address: 8430 Spires Way Frederick 21701 MD
   Company Phone Number: 525-1698   Stock Exchange / Ticker: NASDAQ TOMZ
   TOMZ is expected to report next financial results on March 15, 2024.


Stock Performances by Major Competitors

5 Days Decrease / Increase
• View Complete Report

Kraig Biocraft Laboratories Inc

Revolutionizing the Industry: Chemical Manufacturing Giant Achieves Extraordinary $0.049196 Million Revenue in Q3 2023 Financial Report

Kraig Biocraft Laboratories Inc (KBLB) is a biotechnology company that specializes in genetic engineering and developing innovative materials using spider silk. With a focus on commercializing spider silk technologies, the company aims to create stronger and more versatile materials for various industrial applications.
In the fiscal time-frame from July to September 2023, Kraig Biocraft Laboratories Inc reported a revenue of $0.049196 million. While this might seem relatively low, it is noteworthy considering the company's focus on research and development, which often generates revenue in the later stages of product development.

Qsam Biosciences Inc

Qsam Biosciences Inc. Faces Operating Shortfall in Third Quarter of 2023 Amidst Growing Challenges

/>As the fiscal period of July to September 2023 continues, several companies, particularly in the Chemical Manufacturing industry, have released their financial results. Among them, Qsam Biosciences Inc. recently announced its earnings for the third quarter of 2023. This article aims to interpret the financial results and speculate on how these improvements in the company's operations may impact its future.
Improved Efficiency in Q3 2023:
Qsam Biosciences Inc. has made significant strides in increasing its operational efficiency during Q3 2023. The company reported an operating shortfall of $-1.159112 million, which compares favorably to the previous fiscal period's operating shortfall of $-1.214997 million. This decrease in the shortfall indicates that the company's management has successfully operated the business more competently.

Stratos Renewables Corporation

Stratos Renewables Corporation Releases Impressive Q3 2023 Numbers Alongside Other Businesses

Stratos Renewables Corporation, a company operating in the Chemical Manufacturing industry, recently reported its earnings for the fiscal period of July to September 30, 2023. Despite the challenging economic conditions, the company published an operating deficit of $-0.518461 million for the three-month period, highlighting the current stage of the firm.
Comparing these results to the same period in the previous year, the operating deficit in the third quarter of 2022 was $-0.023341 million. This indicates a significant increase in the deficit, suggesting a growing financial challenge for Stratos Renewables Corporation.

Blue Biofuels Inc

Chemical Manufacturer Delivers Astonishing Results, Achieving Genuine Profit in Recent Fiscal Period Despite Operating Loss of $-0.512834 Million

Blue Biofuels Inc's latest financial results provide an encouraging outlook for the company's performance during the July to September 2023 earnings cycle. Despite a slight decline in revenue, significant progress has been made in reducing operating losses, which positions the company as a potential industry leader. Furthermore, recent market activity indicates a resurgence in investor confidence, manifesting in a notable increase in share price over the past five trading days.
Revenue Stability and Operating Loss Reduction:
In the fiscal period from July to September 2023, Blue Biofuels Inc experienced stability in its revenue, aligning with stockholders' expectations. This consistency signals resilience in the face of market fluctuations and a steady demand for the company's offerings.

Pure Bioscience Inc

Pure Bioscience Inc Experiences Surge in Revenue, Yet Fails to Achieve Profitability in Fiscal Year 2023

Pure Bioscience Inc, a Chemical Manufacturing company, has reported mixed financial results in the fiscal time-frame ending July 31, 2023. While the company experienced a surge in revenue by 46.117%, reaching $0.60 million, it also incurred a net loss of $-0.01 per share. Comparatively, in the same reporting period a year ago, Pure Bioscience Inc had revenue of $0.41 million and a net loss of $-0.01 per share.
The notable aspect of Pure Bioscience Inc's performance is that it has resisted the downward trend observed within the Chemical Manufacturing industry, where most of its contemporaries have faced a decline in revenue. This suggests that the company has successfully managed to buck the industry trend and achieve growth in its top-line.


Tomi Environmental Solutions Inc's Segments
• View Complete Report


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com